Prognostic Factors for COVID-19 Pneumonia Progression to Severe Symptoms Based on Earlier Clinical Features: A Retrospective Analysis

Abstract

Approximately 15–20% of COVID-19 patients will develop severe pneumonia, and about 10% of these will die if not properly managed. Earlier discrimination of potentially severe patients basing on routine clinical and laboratory changes and commencement of prophylactical management will not only save lives but also mitigate the otherwise overwhelming healthcare burden. In this retrospective investigation, the clinical and laboratory features were collected from 125 COVID-19 patients who were classified into mild (93 cases) or severe (32 cases) groups according to their clinical outcomes after 3–7 days post-admission. The subsequent analysis with single-factor and multivariate logistic regression methods indicated that 17 factors on admission differed significantly between mild and severe groups but that only comorbidity with underlying diseases, increased respiratory rate (>24/min), elevated C-reactive protein (CRP >10 mg/L), and lactate dehydrogenase (LDH >250 U/L) were independently associated with the later disease development. Finally, we evaluated their prognostic values with receiver operating characteristic curve (ROC) analysis and found that the above four factors could not confidently predict the occurrence of severe pneumonia individually, though a combination of fast respiratory rate and elevated LDH significantly increased the predictive confidence (AUC = 0.944, sensitivity = 0.941, and specificity = 0.902). A combination consisting of three or four factors could further increase the prognostic value. Additionally, measurable serum viral RNA post-admission independently predicted the severe illness occurrence. In conclusion, a combination of general clinical characteristics and laboratory tests could provide a highly confident prognostic value for identifying potentially severe COVID-19 pneumonia patients.

Abnormal Liver Function Test in Patients Infected with Coronavirus (SARS-CoV-2): A Retrospective Single-Center Study from Spain

“…The pathogenesis of COVID-19 has been also linked with the development of respiratory failure and hypoxia [ 2 ]. Hence there is convincing evidence linking high LDH levels with severe COVID-19 pneumonia and mortality [ 33 , 34 , 35 ]. Moreover, the normalization of serum LDH was consistently accurate in predicting treatment success of the patients [ 36 ].…”

Diabetes mellitus as a comorbidity in COVID-19 infection in the United Arab Emirates

“…Severity of COVID-19 infection was classified based on the following criteria, as previously described. 24 The patient is placed in the mild to moderate group if there was no pneumonia or mild pneumonia, while the severe patients were those that had dyspnea, respiratory rate ≥30/min, blood oxygen saturation ≤93% in resting state, ratio of partial pressure of arterial oxygen (PaO 2 ) to fraction of inspired oxygen (FiO 2 ) ≤300 mm Hg, and lung infiltrates >50% within 24-48 hours. The critical patients were those that had a respiratory failure, septic shock, or multi organ dysfunction/failure.…”

Machine learning approaches in COVID-19 diagnosis, mortality, and severity risk prediction: A review

“…Huang et al [ 79 ] developed a model to predict progression to severe symptoms among COVID-19 patients. The study used a data set of 125 COVID-19 patients (93 mild disease, 32 severe) from Guangzhou Eighth People's Hospital, China.…”